In this video Prof Andrew Coats (University of Warwick, Coventry, UK) and Prof Scott Solomon (Harvard Medical School, Boston, MA, US) discuss current guidelines, recent data and future practices in relation to SGLT2i in heart failure.

Filmed on site at ESC 2019 by Radcliffe Cardiology.

This interview is a component of a wider Radcliffe Education programme entitled,'Current and emerging data on SGLT2 inhibitors in heart failure'. Certified accreditation of the full programme is pending following application to the European Board for Accreditation in Cardiology (EBAC). Once accredited the programme will be available on www.radcliffeeducation.com.

Videographer: Tom Green

This video was partially funded by an unrestricted educational grant from AstraZeneca.